Comparison of Biomarker Expressivity in the Esophageal Metaplasia-Dysplasia-Adenocarcinoma Sequence
Sostin N, Sostin O, Fiedler P, Campbell J. Comparison of Biomarker Expressivity in the Esophageal Metaplasia-Dysplasia-Adenocarcinoma Sequence. American Journal Of Clinical Pathology 2018, 150: s52-s52. DOI: 10.1093/ajcp/aqy090.128.Peer-Reviewed Original ResearchHigh-grade dysplasiaLow-grade dysplasiaHigh-risk lesionsEsophageal adenocarcinomaIHC stainsCyclin D1Invasive adenocarcinomaTissue microarrayMucosal biopsy specimensDepartment of PathologyP53 staining patternMucosal biopsiesDanbury HospitalHistologic diagnosisBiopsy specimensEsophageal dysplasiaMetaplasia-dysplasiaImmunohistochemical stainsClinical utilityBiopsy tissueLethal cancersPositive stainingAdenocarcinomaAdenocarcinoma sequenceIntensity staining